Skip to Content

HPV-driven cancers:using etiology to inform primary and secondary prevention, Aimee R. Kreimer, Ph.D.

DCEG Seminar

 

KreimerSpeaker: Aimée R. Kreimer, Ph.D.

Investigator, Infections and Immunoepidemiology Branch

Division of Cancer Epidemiology and Genetics

National Cancer Institute

 

Description: In this talk, Dr. Kreimer will summarize her current research on the efficacy of the HPV vaccine at multiple anatomic sites, the potential for reduced dosing of these vaccines, and finally, the etiology and prevention potential of HPV16 E6 as it relates to HPV-driven cancers.  

Dr. Kreimer focuses her research on the etiology and prevention of human-papillomavirus associated cancers of the head and neck and anogenital sites.  Dr. Kreimer received a Ph.D. in Infectious Disease Epidemiology from the Johns Hopkins Bloomberg School of Public Health in 2003.  She conducted post-doctoral research at both the International Agency for Research on Cancer in Lyon, France, as well as the NCI.  In 2008, she was appointed to the position of tenure-track Investigator within the Infections and Immunoepidemiology Branch. In that capacity, she continues to focus her research on HPV and cancers at multiple sites. Dr. Kreimer serves as co-Primary Investigator on the Long-term follow-up of the Costa Rica Vaccine Trial, where she focuses on the evaluation of the long-term efficacy of the HPV vaccine at the cervix, anus, and oral region, as well as the efficacy among women who received reduced doses of the HPV vaccine within the trial.  Other on-going research interests include the development of biomarkers for HPV-driven oropharyngeal cancers, and the descriptive epidemiology of oral HPV infection among individuals without cancer.